Status:
COMPLETED
Gene Expression Profiles to Categorize Wilms Tumors
Lead Sponsor:
Children's Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Recurrent Wilms Tumor and Other Childhood Kidney Tumors
Stage I Wilms Tumor
Eligibility:
All Genders
Brief Summary
This laboratory study is using gene expression profiling to identify different categories of Wilms tumors. Studying the genes expressed in samples of tumor tissue from patients with cancer may help do...
Detailed Description
OBJECTIVES: I. Identify new molecular categories of Wilms tumor (WT) based on the gene expression profiles of samples from patients with this disease. II. Develop a classifying system (classifier) t...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Specimens from patients previously enrolled as "On Study" or "Followed Biology Only" on protocol NWTSG-5 (COG-Q9401)
- Study follow-up data for disease status available
- National Wilms Tumor Study Group/Children's Oncology Group pathology review showing "favorable" histology
- Sufficient biology samples available without using biology bank reserves
Exclusion
Key Trial Info
Start Date :
February 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00897637
Start Date
February 1 2004
Last Update
May 19 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Oncology Group
Arcadia, California, United States, 91006-3776
2
Saint Mary's Hospital
West Palm Beach, Florida, United States, 33407